T

Thryv Therapeutics Inc.

21 employees

Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2019

Funding rounds raised

Total raised

$19M

from 2 investors over 2 rounds

T

Thryv Therapeutics Inc. raised $19M on August 10, 2021

Investors: Lumira Ventures and Amplitude Ventures

FAQ